publicações selecionadas
-
artigo académico
- Herbacetin Inhibits Human Fructose 1,6-Bisphosphatase Among a Panel of Chromone Derivatives and Pyrazoles, Demonstrating Positive Effects on Insulin-Resistant HepG2 Cells. Chemical Biology & Drug Design. 2024
- Pyrazoles have a multifaceted anti-inflammatory effect targeting prostaglandin E2, cyclooxygenases and leukocytes’ oxidative burst. International Journal of Biochemistry & Cell Biology. 2024
- An In Silico and an In Vitro Inhibition Analysis of Glycogen Phosphorylase by Flavonoids, Styrylchromones, and Pyrazoles. Nutrients. 2022
- Implementation of a Pull System-A Case Study of a Polymeric Production System for the Automotive Industry. Management Systems in Production Engineering. 2021
- A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes a-amylase and a-glucosidase by chalcone derivatives.. Food Bioscience. 2019
- Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer 2016
- Ohmic heating as a new efficient process for organic synthesis in water. Green Chemistry. 2013
-
capítulo de livro
-
documento
- Polyphenols as potential modulators of type 2 diabetes mellitus through the inhibition of glycogen phosphorylase 2021
- The effect of pyrazoles on the emerging diabetic therapeutic targets: protein tyrosine phosphatase 1b and glycogen phosphorylase 2021
- Antidiabetic Potential of Pyrazoles: Exploring the Structure-Activity Relationship against Protein Tyrosine Phosphatase 1b and Glycogen Phosphorylase 2021
- Insight into the protein tyrosine phosphatase 1B (PTP1B) inhibitory activity of pyrazoles 2020
- O school bus: uma medida para a descarbonização 2020
- Selection of Novel Peptides Homing Alternative Targets in Triple Negative Breast Cancer 2017
- Identification of a novel peptide with high affinity towards breast cancer cells 2015
- Targeted therapy using phage technology: A computational and experimental breast cancer study 2014
- A flexible-docking approach for the design of novel cancer peptidomimetic drugs 2014